About Curtis Scribner
Form D filings for FlightPath Biosciences from 2020 to 2024 list Curtis Scribner as director.
Curtis Scribner first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Curtis Scribner in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Curtis Scribner works with at each company, as listed on that company's latest Form D.
FlightPath Biosciences, Inc. · Form D/A, Oct 24, 2024
MT
Matthew Tindall
President and director
CL
Cristina Larkin
Director